Department of Biochemistry and Molecular Cell Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Section on Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Cell Rep. 2021 Jan 12;34(2):108624. doi: 10.1016/j.celrep.2020.108624.
Thermoneutral conditions typical for standard human living environments result in brown adipose tissue (BAT) involution, characterized by decreased mitochondrial mass and increased lipid deposition. Low BAT activity is associated with poor metabolic health, and BAT reactivation may confer therapeutic potential. However, the molecular drivers of this BAT adaptive process in response to thermoneutrality remain enigmatic. Using metabolic and lipidomic approaches, we show that endogenous fatty acid synthesis, regulated by carbohydrate-response element-binding protein (ChREBP), is the central regulator of BAT involution. By transcriptional control of lipogenesis-related enzymes, ChREBP determines the abundance and composition of both storage and membrane lipids known to regulate organelle turnover and function. Notably, ChREBP deficiency and pharmacological inhibition of lipogenesis during thermoneutral adaptation preserved mitochondrial mass and thermogenic capacity of BAT independently of mitochondrial biogenesis. In conclusion, we establish lipogenesis as a potential therapeutic target to prevent loss of BAT thermogenic capacity as seen in adult humans.
在典型的人类居住环境的热中性条件下,棕色脂肪组织(BAT)会发生萎缩,其特征是线粒体质量减少和脂质沉积增加。BAT 活性低与代谢健康状况不佳有关,BAT 的重新激活可能具有治疗潜力。然而,BAT 对热中性反应的这种适应性过程的分子驱动因素仍然是个谜。我们使用代谢和脂质组学方法表明,内源性脂肪酸合成受碳水化合物反应元件结合蛋白(ChREBP)调节,是 BAT 萎缩的核心调节因子。ChREBP 通过对脂生成相关酶的转录控制,决定了已知调节细胞器周转和功能的储存和膜脂质的丰度和组成。值得注意的是,在热中性适应过程中,ChREBP 缺乏和脂生成的药理学抑制独立于线粒体生物发生,维持了 BAT 中线粒体的质量和产热能力。总之,我们确定脂肪生成是预防成人 BAT 产热能力丧失的一个潜在治疗靶点。